AKT1 and breast carcinoma: In colon and breast cancer cells, CK2 has been shown to promote activation of PI3K/Akt/mTOR, NF-κB and JAK/STAT signaling pathways related to the acquisition of malignant traits, such as exacerbated proliferation and death resistance (25–27).